- 20-05-2021ext abstract:
- 19-03-2021test abstract 2
- 19-03-2021Test text abstract
- 08-09-2020Background The glucose lowering glucagon-like peptide-1 receptor (GLP1R) agonists are currently used in the clinic for the treatment of type…
- 08-09-2020Background The glucose lowering glucagon-like peptide-1 receptor (GLP1R) agonists are currently used in the clinic for the treatment of type…
- 08-09-2020Background The glucose lowering glucagon-like peptide-1 receptor (GLP1R) agonists are currently used in the clinic for the treatment of type…
- 08-09-2020Background The glucose lowering glucagon-like peptide-1 receptor (GLP1R) agonists are currently used in the clinic for the treatment of type…
- 08-09-2020Background The glucose lowering glucagon-like peptide-1 receptor (GLP1R) agonists are currently used in the clinic for the treatment of type…
- 08-09-2020Background The glucose lowering glucagon-like peptide-1 receptor (GLP1R) agonists are currently used in the clinic for the treatment of type…
- 08-09-2020Background The glucose lowering glucagon-like peptide-1 receptor (GLP1R) agonists are currently used in the clinic for the treatment of type…
